Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
about
beta-Lactamases in laboratory and clinical resistanceSusceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection.In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infectionsPharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaCurrent antimicrobial therapy of anaerobic infections.Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.Bacterial challenges and evolving antibacterial drug strategy.Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infectionsRole of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.β-lactam/β-lactamase inhibitor combinations: from then to now.Screening and isolation of antibiotic resistance inhibitors from herb materials IV-resistance inhibitors from Anetheum graveolens and Acorus gramineus.Efficacy, pharmacokinetic and pharmacodynamic profile of ceftolozane + tazobactam in the treatment of complicated urinary tract infections.Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.Beta-lactam resistance in anaerobic bacteria: a review.In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.Antimicrobial activity and pharmacology.Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy.Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤ 1500 g.Piperacillin/tazobactam in complicated urinary tract infections.
P2860
Q24669605-CB426FF1-6503-463F-86B7-DC0D7CC8C93EQ33744238-6118384E-6EDA-4EEB-ADBC-4B0F070043D2Q33761118-FB420612-1649-4854-85B4-CA01F2DD136AQ33977338-CE61F030-561A-46A1-8A70-6F879E22CBE1Q35122283-A182D29F-B25C-4053-94D5-B9C8C8828AB6Q35139002-0ED08463-FAF2-4B42-BF66-4BF74EB45C7FQ35155857-643C62A2-0AAB-4E85-AE87-3402CA088E7FQ35212734-32210F55-65EB-496B-B9FB-A99500868E41Q35896975-55340446-EE5A-4DBA-B7C3-E22E95AA365CQ35900491-90405209-A4CE-41F7-A483-CB258411F487Q35990358-C112ACD8-046D-454C-8C0D-A4152C16EC25Q36171570-2F4A7848-8BB0-4CD1-A8C4-E03E6439EA68Q36753643-C60AADB1-144A-4989-A3BE-0DB2B475451DQ36839703-F701B4E8-01DC-454F-9863-CE28CEF8D446Q37514259-374A1FCB-E2C8-47A2-9EEB-C0BB46ECBBEBQ37624562-8367A8F5-FEBE-4F3B-8FF3-31E10F039817Q38264182-907C1F25-FFC4-49A9-BB07-EA9365F39291Q38528405-D0F457F7-B2E0-497C-8F06-A9B3C7C4CE62Q38872130-66A9AA5A-BC34-4657-A39A-EFE9893E2698Q39865634-7C7D2CEA-7273-44A6-9E4E-A0E50AEEB72AQ39866597-0F0D86D5-36AD-4507-A4D3-F656457DC1FFQ39867395-5D6BFD1E-389F-4EA1-B08F-D81B47B8DB6CQ40284229-C2A72678-4152-47FB-91F8-2F1D8C0768CCQ40471195-F46FBF91-3811-48EE-94DF-C745DB9E9961Q40723790-DC35C27C-5895-49B4-B6FC-A61BF0BCB6D4Q41134735-FCF2A471-73F1-44BF-8D20-CE2F87D477CFQ43126004-1E311CFA-BD90-42EC-914E-39B58189DE8FQ43436023-0AE96F32-CD65-4494-9652-E5BC710476B8Q54200563-B9CFBE7B-F708-4E9E-9505-20E5C4AFEB9DQ54246543-8E8A3C09-3957-4185-ABC6-A7FDC9FEAD33Q54318853-66072B1B-79F4-488D-81E3-BDD97167CCBFQ54631175-2862E283-AA57-4AFD-9B50-6911CE7042A4
P2860
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@ast
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@en
type
label
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@ast
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@en
prefLabel
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@ast
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@en
P2093
P2860
P356
P1476
Comparative in vitro and in vi ...... lavulanic acid, and sulbactam.
@en
P2093
P2860
P304
P356
10.1128/AAC.33.11.1964
P407
P577
1989-11-01T00:00:00Z